Pomalidomide, dexamethasone and ixazomib vs pomalidomide and dexamethasone for patients with multiple myeloma relapsing on lenalidomide as part of first line therapy

April 19, 2019
https://clinicaltrials.gov/ct2/show/NCT02004275
Cancer - Myeloma
Principal Investigator: Jessica M Bensenhaver, MD
Myeloma
Accepting Participants
(313)916-1784